Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2025-12-24 @ 7:21 PM
NCT ID:
NCT02691403
Eligibility Criteria:
Inclusion Criteria:
* A physical status between ASA I and III
* 20 - 75 years of age
* Patient has signed an informed consent
* Without contraindication of QL block
Exclusion Criteria
* American Society of Anesthesiologists (ASA) Physical Status ≥ 4
* Any contraindication to nerve blocks (including coagulopathy, abnormal anatomy, infection at the planned QL injection site, and amide-type local anesthetic allergy) pregnancy or breast-feeding
* Severe obesity (body mass index≥ 35 kg/m2)
* Patients with a history of significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal or hepatic disease
* Allergy to NSAIDs
* Infection at the QL injection site
* Patients with major psychosis or drug and alcohol abuse
* Patient unable to comprehend or use the verbal rating pain scoring system or patient-controlled analgesia pump
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT02691403
Study Brief:
Protocol Section:
NCT02691403